首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

AAPS Journal
ISSN：1550-7416

AAPS Journal

AAPS J
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：约1.0个月
新锐分区：医学3区
年发文量：116
影响因子：3.7
JCR分区：Q2

基本信息

AAPS期刊是美国药学科学家协会（AAPS）的官方期刊，发表影响人类和兽医治疗的药学科学各个领域的新颖和重要发现，包括：·药物设计和发现·药物生物技术·生物药剂学、制剂和药物递送·代谢和转运·药代动力学、药效学和药理学·转化研究·临床评价和治疗结果·监管科学我们邀请以下文章类型的投稿：·原创研究文章·综述和小型综述·白色、评论和社论·会议报告·简报/技术报告和快速交流·监管说明·教程·药学科学方案此外，AAPS期刊还发布由客座编辑组织的主题，这些主题集中在我们领域当前感兴趣的特定领域。
1550-7416SCIE/Scopus收录
3.7
点击查看最新影响趋势>
3.2
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：PHARMACOLOGY & PHARMACY
SCIE
Q2
99/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：PHARMACOLOGY & PHARMACY
SCIE
Q1
77/353
96
116
点击查看年发文量趋势图>
3%-约1.0个月-医学-药学
8.1%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
92.24%32.55%4.76%
CiteScore：9.30
SJR：1.307
SNIP：1.388
学科类别分区排名百分位
大类：Pharmacology, Toxicology and Pharmaceutics
小类：Pharmaceutical Science
Q1
24 / 185

期刊高被引文献

Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link—a Workshop Summary Report
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0298-x
Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: “Drug Products, Including Biological Products, that Contain Nanomaterials”
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0329-7
A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung Cancer
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0350-x
PBPK Absorption Modeling: Establishing the In Vitro–In Vivo Link—Industry Perspective
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0292-3
Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0339-5
In Vitro and In Vivo Co-delivery of siRNA and Doxorubicin by Folate-PEG-Appended Dendrimer/Glucuronylglucosyl-β-Cyclodextrin Conjugate
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0327-9
Fit-for-Purpose Quality Control System in Continuous Bioanalysis During Long-Term Pediatric Studies
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0375-1
Incurred Sample Reanalysis: Time to Change the Sample Size Calculation?
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0293-2
Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0334-x
Compensated Hydroxyl Radical Protein Footprinting Measures Buffer and Excipient Effects on Conformation and Aggregation in an Adalimumab Biosimilar
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0358-2
Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0333-y
Anthocyanin Delphinidin Prevents Neoplastic Transformation of Mouse Skin JB6 P+ Cells: Epigenetic Re-activation of Nrf2-ARE Pathway
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0355-5
“Development of Fixed Dose Combination Products” Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development Strategy
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0346-6
Estimation of Solid Tumor Doubling Times from Progression-Free Survival Plots Using a Novel Statistical Approach
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0302-5
A Systems Pharmacology Model for Drug Delivery to Solid Tumors by Antibody-Drug Conjugates: Implications for Bystander Effects
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0390-2
Theoretical Considerations for Direct Translation of Unbound Liver-to-Plasma Partition Coefficient from In Vitro to In Vivo
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0314-1
Evaluating a Multiscale Mechanistic Model of the Immune System to Predict Human Immunogenicity for a Biotherapeutic in Phase 1
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0361-7
Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0340-z
Quality Controls in Ligand Binding Assays: Recommendations and Best Practices for Preparation, Qualification, Maintenance of Lot to Lot Consistency, and Prevention of Assay Drift
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0354-6
On the Comparison of Methods in Analyzing Bounded Outcome Score Data
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0370-6
Scaling Drug Clearance from Adults to the Young Children for Drugs Undergoing Hepatic Metabolism: A Simulation Study to Search for the Simplest Scaling Method
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0295-0
TCPro: an In Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0368-0
Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0381-3
Reengineering of Albumin-Fused Cocaine Hydrolase CocH1 (TV-1380) to Prolong Its Biological Half-Life
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0377-z
CAR T Cell Immunotherapy in Human and Veterinary Oncology: Changing the Odds Against Hematological Malignancies
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0322-1
A Fit-for-Purpose Method for the Detection of Human Antibodies to Surface-Exposed Components of BMS-986263, a Lipid Nanoparticle-Based Drug Product Containing a siRNA Drug Substance
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0360-8
Fetal Concentrations of Budesonide and Fluticasone Propionate: a Study in Mice
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0313-2
Neutralizing Antibody Assay Development with High Drug and Target Tolerance to Support Clinical Development of an Anti-TFPI Therapeutic Monoclonal Antibody
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0320-3
In Vitro Metabolism and Hepatic Intrinsic Clearance of the Synthetic Cannabinoid Receptor Agonist JWH-122 and Its Four ω-Halogenated Analogues
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0338-6
Population Pharmacokinetics and Pharmacodynamics of Apixaban Linking Its Plasma Concentration to Intrinsic Activated Coagulation Factor X Activity in Japanese Patients with Atrial Fibrillation
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0353-7
Modeling Combined Anti-Inflammatory Effects of Dexamethasone and Tofacitinib in Arthritic Rats
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0362-6
Deconvolution Analysis by Non-linear Regression Using a Convolution-Based Model: Comparison of Nonparametric and Parametric Approaches
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0389-8
Anti-drug Antibody Assay Validation: Improved Reporting of the Assay Selectivity via Simpler Positive Control Recovery Data Analysis
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0347-5
Phase-Appropriate Application of Analytical Methods to Monitor Subvisible Particles Across the Biotherapeutic Drug Product Life Cycle
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0384-0
Mechanistic Deconvolution of Oral Absorption Model with Dynamic Gastrointestinal Fluid to Predict Regional Rate and Extent of GI Drug Dissolution
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0385-z
Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0294-1
Model-Based Conditional Weighted Residuals Analysis for Structural Model Assessment
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0305-2
Estimating In Vivo Fractional Contribution of OATP1B1 to Human Hepatic Active Uptake by Mechanistically Modeling Pharmacogenetic Data
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0337-7
Simulating the Impact of Elevated Levels of Interleukin-6 on the Pharmacokinetics of Various CYP450 Substrates in Patients with Neuromyelitis Optica or Neuromyelitis Optica Spectrum Disorders in Different Ethnic Populations
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0309-y
Inhibition of Hepatic CYP2D6 by the Active N-Oxide Metabolite of Sorafenib
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0374-2
Current Perspectives on Ligand-Binding Assay Practices in the Quantification of Circulating Therapeutic Proteins for Biosimilar Biological Product Development
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0397-8
Multiplexed Gene Expression as a Characterization of Bioactivity for Interferon Beta (IFN-β) Biosimilar Candidates: Impact of Innate Immune Response Modulating Impurities (IIRMIs)
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0300-7
Dissolution Chamber for Small Drug Delivery System in the Periodontal Pocket
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0317-y
Correction to: A Translational Quantitative Systems Pharmacology Model for CD3 Bispecific Molecules: Application to Quantify T Cell-Mediated Tumor Cell Killing by P-Cadherin LP DART®
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0348-4
Variability Attribution for Automated Model Building
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0310-5
Systemic Bioequivalence Is Unlikely to Equal Target Site Bioequivalence for Nanotechnology Oncologic Products
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0296-z
A Novel Method for Analysing Frequent Observations from Questionnaires in Order to Model Patient-Reported Outcomes: Application to EXACT® Daily Diary Data from COPD Patients
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0319-9
Population Pharmacokinetic Modeling in the Presence of Missing Time-Dependent Covariates: Impact of Body Weight on Pharmacokinetics of Paracetamol in Neonates
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0331-0
Analysis of the Regulatory Divergence of Comparative Dissolution Requirements for Post-Approval Manufacturing Changes of Modified Release Solid Oral Dosage Forms
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0383-1
Induction and Impact of Anti-Drug Responses Elicited by a Human Recombinant Coagulation Factor FXaI16L in Preclinical Species
来源期刊：The AAPS JournalDOI：10.1208/s12248-019-0324-z

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

AAPS Journal封面

AAPS Journal

学科领域：医学
影响因子：3.7
中科院分区： 3区
AAPS PHARMSCITECH封面

AAPS PHARMSCITECH

学科领域：医学
影响因子：4
中科院分区： 3区
Academic Pediatrics封面

Academic Pediatrics

学科领域：医学
影响因子：2.8
中科院分区： 3区
ACTA ANAESTHESIOLOGICA SCANDINAVICA封面

ACTA ANAESTHESIOLOGICA SCANDINAVICA

学科领域：医学
影响因子：2
中科院分区： 3区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布
大类学科小类学科Top期刊综述期刊
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
否
否